Stefan Knackmuss

1.7k total citations
41 papers, 1.4k citations indexed

About

Stefan Knackmuss is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Immunology. According to data from OpenAlex, Stefan Knackmuss has authored 41 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Radiology, Nuclear Medicine and Imaging, 22 papers in Oncology and 15 papers in Immunology. Recurrent topics in Stefan Knackmuss's work include Monoclonal and Polyclonal Antibodies Research (31 papers), CAR-T cell therapy research (18 papers) and Cell Adhesion Molecules Research (8 papers). Stefan Knackmuss is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (31 papers), CAR-T cell therapy research (18 papers) and Cell Adhesion Molecules Research (8 papers). Stefan Knackmuss collaborates with scholars based in Germany, South Africa and United States. Stefan Knackmuss's co-authors include Melvyn Little, Uwe Reusch, Stefan Weiß, Fabrice Le Gall, Ivica Fucek, Eugene A. Zhukovsky, Kristina Ellwanger, Bianca Da Costa Dias, Karin Hoffmann‐Sommergruber and Peter Borchmann and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Stefan Knackmuss

38 papers receiving 1.3k citations

Peers

Countries citing papers authored by Stefan Knackmuss

Since Specialization

Citations

This map shows the geographic impact of Stefan Knackmuss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Knackmuss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Knackmuss more than expected).

Fields of papers citing papers by Stefan Knackmuss

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan Knackmuss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Knackmuss. The network helps show where Stefan Knackmuss may publish in the future.

Co-authorship network of co-authors of Stefan Knackmuss

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Knackmuss. A scholar is included among the top collaborators of Stefan Knackmuss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Knackmuss. Stefan Knackmuss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	AFM26 - Targeting B Cell Maturation Antigen (BCMA) for NK Cell-Mediated Immunotherapy of Multiple Myeloma 2017 ·Blood ·Thorsten Gantke, Uwe Reusch, Christian Kellner, Katja Klausz, (unknown), Stefan Knackmuss, Thomas Müller, Kristina Ellwanger, Ivica Fucek, (unknown), Joachim Koch, A. Kerber, Matthias Peipp, Martin Treder	6
2	Highly Specific and Effective Targeting of EGFRvIII-Positive Tumors with TandAb Antibodies 2017 ·Frontiers in Oncology ·Kristina Ellwanger, Uwe Reusch, Ivica Fucek, Stefan Knackmuss, Michael Weichel, Thorsten Gantke, (unknown), Eugene A. Zhukovsky, Michael Tesar, Martin Treder	25
3	Characterization of CD33/CD3 Tetravalent Bispecific Tandem Diabodies (TandAbs) for the Treatment of Acute Myeloid Leukemia 2016 ·Clinical Cancer Research ·Uwe Reusch, Kimberly H. Harrington, Chelsea J. Gudgeon, Ivica Fucek, Kristina Ellwanger, Michael Weichel, Stefan Knackmuss, Eugene A. Zhukovsky, Judith A. Fox, Lori Kunkel, Jeanmarie Guenot, Roland B. Walter	76
4	A tetravalent bispecific TandAb (CD19/CD3), AFM11, efficiently recruits T cells for the potent lysis of CD19⁺tumor cells 2015 ·mAbs ·Uwe Reusch, Johannes Duell, Kristina Ellwanger, (unknown), Stefan Knackmuss, Ivica Fucek, Markus Eser, Fionnuala McAleese, (unknown), Fabrice Le Gall, Max S. Topp, Melvyn Little, Eugene A. Zhukovsky	110
5	Knock-Down of the 37kDa/67kDa Laminin Receptor LRP/LR Impedes Telomerase Activity 2015 ·PLoS ONE ·(unknown), Sibusiso T. Malindisa, (unknown), (unknown), Bianca Da Costa Dias, (unknown), Uwe Reusch, Stefan Knackmuss, Melvyn Little, Stefan Weiß, Boitelo T. Letsolo	24
6	Construction and characterization of novel CD33/CD3 tandem diabodies (TandAbs) for the treatment of acute myeloid leukemia (AML). 2015 ·Journal of Clinical Oncology ·Uwe Reusch, Kimberly H. Harrington, Chelsea J. Gudgeon, Ivica Fucek, Kristina Ellwanger, Michael Weichel, Stefan Knackmuss, Eugene A. Zhukovsky, Judith A. Fox, Jeanmarie Guenot, Roland B. Walter	2
7	The 37kDa/67kDa Laminin Receptor acts as a receptor for Aβ42 internalization 2014 ·Scientific Reports ·Bianca Da Costa Dias, Katarina Jovanović, (unknown), (unknown), Uwe Reusch, Stefan Knackmuss, Marc S. Weinberg, Melvyn Little, Stefan Weiß	35
8	Anti-LRP/LR specific antibodies and shRNAs impede amyloid beta shedding in Alzheimer's disease 2013 ·Scientific Reports ·Katarina Jovanović, (unknown), Bianca Da Costa Dias, (unknown), Uwe Reusch, Stefan Knackmuss, Clement Penny, Marc S. Weinberg, Melvyn Little, Stefan Weiß	25
9	In Vitro Inhibition of Angiogenesis by Antibodies Directed against the 37kDa/67kDa Laminin Receptor 2013 ·PLoS ONE ·(unknown), Bianca Da Costa Dias, (unknown), Clement Penny, Uwe Reusch, Stefan Knackmuss, Melvyn Little, Stefan Weiß	33
10	Adhesion and Invasion of Breast and Oesophageal Cancer Cells Are Impeded by Anti-LRP/LR-Specific Antibody IgG1-iS18 2013 ·PLoS ONE ·(unknown), Uwe Reusch, Stefan Knackmuss, Melvyn Little, (unknown), Stefan Weiß	33
11	Anti-LRP/LR specific antibody IgG1-iS18 and knock-down of LRP/LR by shRNAs rescue cells from Aβ42 induced cytotoxicity 2013 ·Scientific Reports ·Bianca Da Costa Dias, Katarina Jovanović, (unknown), (unknown), Uwe Reusch, Stefan Knackmuss, Clement Penny, Marc S. Weinberg, Melvyn Little, Stefan Weiß	22
12	Anti-LRP/LR-Specific Antibody IgG1-iS18 Significantly Reduces Adhesion and Invasion of Metastatic Lung, Cervix, Colon and Prostate Cancer Cells 2012 ·Journal of Molecular Biology ·(unknown), Uwe Reusch, Stefan Knackmuss, Melvyn Little, Stefan Weiß	42
13	Abstract 4624: High affinity CD3 RECRUIT-TandAbs for T cell-mediated lysis of malignant CD19+ B cells 2012 ·Cancer Research ·Uwe Reusch, Carmen Burkhardt, Stefan Knackmuss, Ivica Fucek, Markus Eser, Fionnuala McAleese, Thomas M. A. Gronewold, Eugene A. Zhukovsky, Melvyn Little	1
14	68Ga-labelled recombinant antibody variants for immuno-PET imaging of solid tumours 2010 ·European Journal of Nuclear Medicine and Molecular Imaging ·Matthias Eder, Stefan Knackmuss, Fabrice Le Gall, Uwe Reusch, Vladimir Rybin, Melvyn Little, Uwe Haberkorn, Walter Mier, Michael Eisenhut	45
15	Tetrafluorophenolate of HBED-CC: a versatile conjugation agent for 68Ga-labeled small recombinant antibodies 2008 ·European Journal of Nuclear Medicine and Molecular Imaging ·Matthias Eder, Björn Wängler, Stefan Knackmuss, (unknown), Melvyn Little, Uwe Haberkorn, Walter Mier, Michael Eisenhut	87
16	Single chain Fv antibodies directed against the 37 kDa/67 kDa laminin receptor as therapeutic tools in prion diseases 2007 ·Molecular Immunology ·Chantal Zuber, Stefan Knackmuss, Clémence Rey, Uwe Reusch, (unknown), Thomas Fröhlich, Georg J. Arnold, Claudia Pace, Gerda Mitteregger, Hans A. Kretzschmar, Melvyn Little, Stefan Weiß	41
17	Specific inhibition of interleukin-13 activity by a recombinant human single-chain immunoglobulin domain directed against the IL-13 receptor α1 chain 2007 ·Biological Chemistry ·Stefan Knackmuss, S. Krause, Kathrin M. Engel, Uwe Reusch, J. Christian Virchow, Thomas D. Mueller, (unknown), (unknown), Werner Luttmann, Karlheinz Friedrich	6
18	Single‐chain antibodies for the conformation‐specific blockade of activated platelet integrin α _IIb β ₃ designed by subtractive selection from naïve human phage libraries 2004 ·The FASEB Journal ·Meike Schwarz, (unknown), Yoshikazu Takada, Fabrice Le Gall, Stefan Knackmuss, Nicole Bassler, (unknown), Melvyn Little, Christoph Bode, Karlheinz Peter	63
19	Synergistic Antitumor Effect of Bispecific CD19 × CD3 and CD19 × CD16 Diabodies in a Preclinical Model of Non-Hodgkin’s Lymphoma 2002 ·The Journal of Immunology ·Sergey M. Kipriyanov, Björn Cochlovius, Holger Schäfer, Gerhard Moldenhauer, (unknown), Fabrice Le Gall, Stefan Knackmuss, Melvyn Little	66
20	Identification of the gene coding for the largest subunit of RNA polymerase I (A) of Drosophila melanogaster 1997 ·Molecular and General Genetics MGG ·Stefan Knackmuss, (unknown), Gabriele Petersen	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact